Effect of miR-630 expression on esophageal cancer cell invasion and migration

被引:6
|
作者
Liu, Xi [1 ]
Wu, Wei [1 ]
Zhang, Shixin [1 ]
Tan, Wenfeng [1 ]
Qiu, Yang [1 ]
Liao, Kelong [1 ]
Yang, Kang [1 ]
机构
[1] AMU, Hosp 1, 12 Fengtian Ave, Chongqing 400038, Peoples R China
关键词
diagnostic value; esophageal cancer; invasion; migration; miR‐ 630; CIRCULATING MICRORNAS; BREAST-CANCER; BIOMARKERS; DIAGNOSIS; PROGNOSIS; TRENDS; CHINA;
D O I
10.1002/jcla.23815
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background Esophageal cancer (EC) is a common malignancy of the digestive tract, with high incidence. The objective of this study was to investigate the effect of miR-630 expression on esophageal cancer (EC) cell invasion and migration. Methods The study group comprised 58 EC patients admitted to our hospital from April 2014 to 2016, and the control group comprised 60 healthy people visiting the hospital during the same period. miR-630 levels in the peripheral blood of the two groups were compared, and the diagnostic value of miR-630 for EC was analyzed. EC cell lines were used to evaluate the influence of miR-630 expression on EC cell invasion and migration. Results miR-630 expression was low in EC (p < 0.050). A receiver operating characteristic curve analysis showed that miR-630 expression had a good diagnostic value for EC (p < 0.050) and was associated with disease course, pathological stage, differentiation degree, tumor metastasis, and patient prognosis and survival (p < 0.05). The ROC curve analysis showed that when cutoff value was 5.38, the diagnostic sensitivity and specificity of miR-630 for EC were 73.33% and 76.67%, respectively; area under the ROC curve was 0.778 (95%CI 0.695-0.861). Transfection of miR-630 into EC cells indicated that miR-630 overexpression can reduce EC cell invasion and migration (p < 0.05). miR-630 expression is low in EC and has good diagnostic value for EC. Conclusion miR-630 overexpression can reduce EC cell invasion and migration, showing a possible key role of miR-630 in EC diagnosis and treatment in the future.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] MiR-630 inhibits invasion and metastasis in esophageal squamous cell carcinoma
    Jin, Li
    Yi, Jun
    Gao, Yanping
    Han, Siqi
    He, Zhenyue
    Chen, Longbang
    Song, Haizhu
    [J]. ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2016, 48 (09) : 810 - 819
  • [2] Lower miR-630 expression predicts poor prognosis of osteosarcoma and promotes cell proliferation, migration and invasion by targeting PSMC2
    Li, G-W
    Yan, X.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (05) : 1915 - 1925
  • [3] MiR-630 inhibits cells migration and invasion by targeting SOX4 in triple-negative breast cancer
    Liu, Yun-Xiao
    Zhao, Li-Ping
    Zhang, Ya-Li
    Dong, Yan-Yan
    Ren, Hua-Yan
    Diao, Ke-Xin
    Mi, Xiao-Yi
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (09): : 9097 - 9105
  • [4] miR-181a and miR-630 Regulate Cisplatin-Induced Cancer Cell Death
    Galluzzi, Lorenzo
    Morselli, Eugenia
    Vitale, Ilio
    Kepp, Oliver
    Senovilla, Laura
    Criollo, Alfredo
    Servant, Nicolas
    Paccard, Caroline
    Hupe, Philippe
    Robert, Thomas
    Ripoche, Hugues
    Lazar, Vladimir
    Harel-Bellan, Annick
    Dessen, Philippe
    Barillot, Emmanuel
    Kroemer, Guido
    [J]. CANCER RESEARCH, 2010, 70 (05) : 1793 - 1803
  • [5] UP REGULATION OF MIR-630 BY HEAT SHOCK INHIBITS SERTOLI CELL PROLIFERATION, MIGRATION AND IMMATURE SERTOLI CELL MARKER EXPRESSION.
    Lin, Y. -M.
    Lu, C. -W.
    Ma, H. -Y.
    [J]. FERTILITY AND STERILITY, 2014, 102 (03) : E193 - E193
  • [6] MiR-630 suppresses non-small cell lung cancer by targeting vimentin
    Wang, Bin
    Li, Jie
    Li, Yulin
    Liang, Tao
    Chu, Xiangyang
    [J]. JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (09)
  • [7] MiR-630 promotes epithelial ovarian cancer proliferation and invasion via targeting KLF6
    Zhang, S.
    Zhang, J. -Y.
    Lu, L. -J.
    Wang, C. -H.
    Wang, L. -H.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (20) : 4542 - 4547
  • [8] miR-630 functions as a tumor oncogene in renal cell carcinoma
    Zhao, Jian-Jun
    Chen, Peng-Jie
    Duan, Rui-Qin
    Li, Ke-Ji
    Wang, Yu-Zhong
    Li, Yong
    [J]. ARCHIVES OF MEDICAL SCIENCE, 2016, 12 (03) : 473 - 478
  • [9] MiR-630 suppresses breast cancer progression by targeting metadherin
    Zhou, Ci-Xiang
    Wang, Chen-Long
    Yu, An-Lu
    Wang, Qiu-Yu
    Zhan, Meng-Na
    Tang, Jun
    Gong, Xiu-Feng
    Yin, Qian-Qian
    He, Ming
    He, Jian-Rong
    Chen, Guo-Qiang
    Zhao, Qian
    [J]. ONCOTARGET, 2016, 7 (02) : 1288 - 1299
  • [10] miR-630 targets LMO3 to regulate cell growth and metastasis in lung cancer
    Song, Ying-Fang
    Hong, Jing-Fang
    Liu, De-Ling
    Lin, Qing-An
    Lan, Xiao-Peng
    Lai, Guo-Xiang
    [J]. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2015, 7 (07): : 1271 - 1279